Xenon Seven

Xenon Seven

Executive Director, Total Rewards

Vancouver · Director

Sponsorship not specifiedDetected 68 days ago
RESTProject ManagementAccountingForecastingHRPerformance ManagementCompensationClinical TrialsLeadershipCommunicationCollaborationProblem SolvingMentoring

About the role

  • We are seeking an Executive Director, Total Rewards to join our team.
  • In addition, the successful candidate will have proven leadership ability in a fast-paced, multi-jurisdiction environment and will interact with all levels of internal staff, as well as external advisors and suppliers.
  • This is a hands-on role with plans to grow a team in accordance with business need.

Responsibilities

  • Lead and manage incentive compensation for non-Sales employees
  • collaborate on program design with Sales Management and Commercial HRBP for Sales employees
  • work with program lead for performance management to ensure robust and well-articulated program alignment
  • Support the Executive Vice President, Human Resources in managing external compensation consultants and developing materials for the Compensation Committee and Board of Directors
  • Lead and manage non-financial employee recognition programs in collaboration with HRBPs and HR Operations

Requirements

  • Deep hands-on experience and expertise in data and systems, very strong attention to detail
  • Ability to adapt and quickly pivot according to business needs
  • Ability to execute against multiple high priority projects through exceptional organizational, prioritization and project management skills
  • Review and provide input on various compensation governance reports, including, for example, proxy Compensation and Discussion Analysis, collaborating with Finance and Legal as required
  • At minimum a relevant undergraduate degree, including coursework in math, accounting, finance and/or law; MBA strongly preferred
  • Deep business acumen and understanding of how business strategy in biopharma affects total rewards
  • Strong analytical and conceptual capability, problem solving, and business planning skills; ability to develop and successfully execute strategies at an organizational level
  • Excellent written and oral communication skills, including related to compensation context and employee messaging, to executive and non-executive audiences
  • Ability to collaborate effectively and build relationships with key stakeholders
  • Impeccable integrity, dependability, and a keen sense of urgency to achieve results
  • Strong skills in Office software, HR and Finance systems and data
  • Xenon encourages time to rest and re-charge through vacation, personal days, sick days, and an end-of-year company shutdown.
  • Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees.

Nice to have

  • At minimum a relevant undergraduate degree, including coursework in math, accounting, finance and/or law
  • MBA strongly preferred
  • 15+ years of experience in progressive compensation/HR management roles in a public, multi-national company life sciences organizations experiencing rapid growth and change
  • experience in both pre-commercial and commercial companies strongly preferred
  • ideally experience preparing materials for and interacting with the Board and/or Compensation Committee

Compensation

  • Lead and manage the base salary program including, but not limited to, budget and forecast (i.e. workforce planning, annual review), job design and matching, salary ranges (i.e. preparation and approval, maintenance, pay transparency, legal compliance), annual and promotion increase guidance, and metrics & analysis
  • Oversee compensation details to enable accurate forecasting for the Annual Operating Plan and 5-year Plan financial data

Benefits

  • Lead and manage US benefits, including health related and 401(k), from design proposals supported by external advisors and industry benchmarking to contracting to employee communications to governance

Company info

  • Xenon Pharmaceuticals (NASDAQ:XENE https://www.nasdaq.com/market-activity/stocks/xene) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
  • What We Do:
  • We are advancing an exciting product pipeline https://xenon-pharma.com/pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting. We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are important pain targets. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
  • Xenon Pharmaceuticals (NASDAQ:XENE https://www.nasdaq.com/market-activity/stocks/xene) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need.
  • We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
  • We are advancing an exciting product pipeline https://xenon-pharma.com/pipeline to address indications with high unmet medical need, including epilepsy, depression and pain.
  • Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.
  • In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026.
  • Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication.
  • We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial.
  • In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting.
  • We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are important pain targets.
  • Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.

This listing is sourced directly from Xenon Seven's careers page and normalized into a canonical job model.